Fuller & Thaler Asset Management, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Fuller & Thaler Asset Management, Inc.
- $25.4 Billion
- Q1 2025
A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 1,263,598 shares of AMPH stock, worth $31.7 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,263,598
Previous 1,132,926
11.53%
Holding current value
$31.7 Million
Previous $42.1 Million
12.92%
% of portfolio
0.14%
Previous 0.16%
Shares
20 transactions
Others Institutions Holding AMPH
# of Institutions
264Shares Held
32.5MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$149 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$60.9 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.6 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.1 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.23B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...